Skip to main content
. 2023 Jan 15;13(2):316. doi: 10.3390/diagnostics13020316

Table 2.

Clinical and endocrine characteristics of the PCOS cases and controls.

Variable Total (n = 851) Control (n = 644) PCOS (n = 207) p-Value
Age a (years) 33.3 (7.5) 34.1 (7.3) 30.7 (7.5) <0.001
BMI a (kg/m2) 26.7 (5.2) 26.7 (5.1) 26.6 (5.5) 0.8
Number of pregnancy a 2.8 (1.6) 2.9 (1.6) 2.5 (1.5) 0.01
Number of delivery a 2.5 (1.4) 2.5 (1.4) 2.1 (1.3) 0.001
Number of abortion a 0.4 (0.7) 0.4 (0.7) 0.4 (0.6) 0.9
WC a (cm) 83.2 (11.8) 83.1 (11.7) 83.2 (12.3) 0.9
Height a (cm) 158.9 (6.2) 158.9 (6.2) 159.3 (6.1) 0.4
Weight a (kg) 67.3 (13.0) 67.3 (12.8) 67.4 (13.7) 0.9
Hip a (cm) 102.9 (12.2) 102.9 (11.9) 102.9 (13.3) 0.9
WHR a 0.81 (0.09) 0.81 (0.09) 0.81 (0.07) 0.9
WHtR a 0.52 (0.08) 0.52 (0.08) 0.52 (0.08) 0.8
FAI b 1.9 (0.8,3.6) 1.7 (0.7,3.2) 3.3 (1.5,5.4) <0.001 d
FSH b (microU/mL) 7.6 (5.7,9.8) 8.0 (5.9,10.1) 8.9 (6.9,10.4) <0.001 d
LH b (microU/mL) 4.7 (3.4–6.5) 4.6 (3.4–6.4) 4.9 (3.3–7.0) 0.2
LH/FSH b 0.6 (0.42–0.85) 0.58 (0.40–0.81) 0.69 (0.48–0.98) <0.001 d
SHBG b (nmol/L) 56.4 (42.7–81.9) 59.4 (43.8–85.6) 50.5 (40.8–67.5) 0.001 d
DHEAS b (microg/dL) 138.9 (73.6–195.6) 118.9 (65.6–186.7) 179.4 (119.3–221.0) <0.001 d
Testosterone b (nmol/L) 0.35 (0.14–0.61) 0.31 (0.12–0.56) 0.49 (0.24–0.79) <0.001 d
TSH b (microU/mL) 2.1 (1.5–3.4) 2.1 (1.5–3.4) 2.0 (1.4–3.4) 0.2
SCH c 89 (10.5) 65 (10.1) 24 (11.6) 0.5

a Values are presented as mean (SD), b values are expressed as median (Inter Quartile Range), c data shown as number (percentage). Analyzed using independent samples t-test for superscripts a, Mann–Whitney U test for superscripts b and Pearson’s test for superscripts c. PCOS polycystic ovarian syndrome, BMI body mass index, WC waist circumference, WHR waist–hip ratio, WHtR waist-to-height ratio, FAI free androgen index, FSH follicle stimulating hormone, LH luteinizing hormone, FSH follicle stimulating hormone, SHBG sex hormone-binding globulin, DHEAS dehydroepiandrosterone sulfate, TSH thyroid stimulating hormone, SCH subclinical hypothyroidism. d p < 0.001 versus controls after adjusting for age, BMI and parity.